Author

Ellise A. Roper

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Abdul MannaniD· 1 shared Anoop K. EnjetiiD· 1 shared Brooke M. Harvey· 1 shared Carlos RiverosiD· 1 shared Charles E. de BockiD· 1 shared Charley Lawlor-O’Neill· 1 shared Danielle R. BondiD· 1 shared Heather C. MurrayiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdul MannanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hypomethylating agents induce epigenetic and transcriptional heterogeneity with implications for AML cell self-renewal.

Danielle R. Bond, Sean M. Burnard, Kumar Uddipto, Kooper V. Hunt, Brooke M. Harvey, Luiza Steffens Reinhardt, Charley Lawlor-O’Neill, Ellise A. Roper, Sam Humphries, Heather C. Murray, Abdul Mannan, Matthew D. Dun, Charles E. de Bock, Nikola A. Bowden, Anoop K. Enjeti, , Heather J. Lee

This study shows that hypomethylating agents induce epigenetic and transcriptional heterogeneity in AML cells, with some cells retaining methylation and showing increased self-renewal, and identifies statins as a potential co-treatment to enhance HMA efficacy.

bioRxiv · Jan 30, 2024Cancer Biology